Severe hemorrhage in a patient with metastatic colorectal cancer

被引:5
|
作者
Oergel, Melanie [1 ]
Horger, Marius [2 ]
Kurth, Ralph [3 ]
Kanz, Lothar [1 ]
Jaschonek, Karl [1 ]
Mayer, Frank [1 ]
Kopp, Hans-Georg [1 ]
机构
[1] Univ Klinikum Tubingen, Med Klin, Tubingen, Germany
[2] Univ Klinikum Tubingen, Radiol Klin, Tubingen, Germany
[3] Univ Klinikum Tubingen, Inst Allgemeine Pathol, Tubingen, Germany
关键词
Colorectal Cancer; Microangiopathic Hemolysis; Disseminated Intravascular Cogulation; DISSEMINATED INTRAVASCULAR COAGULATION; BONE-MARROW; GASTRIC-CANCER; BREAST-CANCER; SOLID TUMORS; MALIGNANCY; STATE; THROMBOCYTOPENIA;
D O I
10.1055/s-0032-1305227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and admission findings: We report on a 65-year-old female patient with a recent diagnosis of adenocarcinoma of the sigmoid colon and massive hematochezia in the context of a general bleeding disorder. Investigations: Disseminated malignant disease with hepatic metastases as well as bone marrow involvement was demonstrated. Moreover, circulating tumor cells were demonstrated by flow cytometry. The patient had right lower quadrant abdominal pain due to a spontaneous psoas intramuscular hematoma. Diagnosis, treatment and course: At the time of admission to our hospital, the patient displayed microangiopathic hemolytic anemia and secondary hyperfibrinolysis with a pronounced bleeding tendency. Moreover, there was an acute renal failure which improved with fluid resuscitation. With immediate chemotherapy consisting of 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX regimen) and cetuximab initiated with the second course, plasmatic coagulation could be stabilized. Consequently, treatment with tranexamic acid, fibrinogen, fresh frozen plasma as well as red blood cell and platelet infusions could be stopped. Continuation of chemotherapy was possible on an outpatient basis and the further course was associated with a good quality of life until her near end. The patient died at home 7 months after initial diagnosis of her colon cancer due to progressive disease with CNS metastases. Conclusions: Disseminated intravascular coagulation with microangiopathic hemolysis and secondary hyperfibrinolysis is a rare albeit possible event in disseminated colorectal cancer, especially when the bone marrow is involved. Treatment of the underlying cause is the most important therapeutic measure.
引用
收藏
页码:1705 / +
页数:36
相关论文
共 50 条
  • [21] Delayed Oxaliplatin-Related Severe Neurotoxicity in Metastatic Colorectal Cancer: A Case Report
    Iimura, Yohei
    Furukawa, Naoki
    Kuroda, Seiichiro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [22] Metastatic colorectal cancer with severe liver dysfunction successfully treated using FOLFOX therapy
    Shimura T.
    Kataoka H.
    Hirata Y.
    Mizushima T.
    Murakami K.
    Mabuchi M.
    Mizoshita T.
    Kubota E.
    Tanida S.
    Kamiya T.
    Joh T.
    Journal of Gastrointestinal Cancer, 2011, 42 (1) : 68 - 72
  • [23] Regorafenib in metastatic colorectal cancer
    Sartore-Bianchi, Andrea
    Zeppellini, Annalisa
    Amatu, Alessio
    Ricotta, Riccardo
    Bencardino, Katia
    Siena, Salvatore
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (03) : 255 - 265
  • [25] Molecular biomarkers for the detection of metastatic colorectal cancer cells
    Kamiyama, Hidenori
    Noda, Hiroshi
    Konishi, Fumio
    Rikiyama, Toshiki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (27) : 8928 - 8938
  • [26] Precision medicine for metastatic colorectal cancer in clinical practice
    Riedesser, Julian E.
    Ebert, Matthias P.
    Betge, Johannes
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [27] Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program
    Salgado Fernandez, Mercedes
    Perez Hoyos, Maria Teresa
    Diaz de Corcuera, Isabela
    Vidal Arbues, Alba
    Garcia de la Torre, Marta
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1171 - 1179
  • [28] Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer
    Gaulin, J.
    Kotb, R.
    Turcotte, E.
    Berard, G.
    Sawan, B.
    Schmutz, G.
    Beauregard, P.
    CURRENT ONCOLOGY, 2009, 16 (05) : 331 - 333
  • [29] Weekly irinotecan in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure
    Stemmler, J
    Weise, A
    Hacker, U
    Heinemann, V
    Schalhorn, A
    ONKOLOGIE, 2002, 25 (01): : 60 - 63
  • [30] Complete response to capecitabine in a frail, elderly patient with metastatic colorectal cancer: A case report
    Fasano, Morena
    Fabozzi, Alessio
    Giordano, Guido
    Venturini, Filippo
    Aurilio, Gaetano
    Cantile, Flavia
    Fabozzi, Teresa
    Ricci, Vincenzo
    Santabarbara, Giuseppe
    Morgillo, Floriana
    Ciardiello, Fortunato
    De Vita, Ferdinando
    ONCOLOGY LETTERS, 2017, 13 (02) : 979 - 983